Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications

Introduction to the session

The aim of this summary report is to capture the content of the session at EuroPCR 2018 that reviewed the implications for clinical practice of the SPYRAL HTN-ON MED study1, in order to share the critical analysis of the trial and report the views expressed in the interactive discussion. This article does not constitute an independent review of the topic by the authors.

What was known before SPYRAL HTN-ON MED?

Hypertension is highly prevalent around the world and is associated with cardiovascular morbidity and death. However, blood pressure (BP) control remains unacceptably low ...